GlassScriptPrepare for your visit
Joel H Ross
Obstetrics & Gynecology · Newark, NJ · NPI 1336407824
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$14,721.31
in general payments reported to CMS, 2019-2025 · $10K in 2025
The $10K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Who reported paying
General payments only, top 6 by amount.
- Mimedx Group, INC. $14,400.00
- Ethicon US, LLC $86.55
- Hologic Sales and Service, LLC $37.62
- Mayne Pharma Commercial LLC $34.79
- Abbvie INC. $32.80
- Biogen, INC. $29.80
Drugs and devices associated with these payments
Bovine Collagen Echelon Flex Stratafix Vistaseal Evarrest Zurzuvae Aptima Freestyle Libre 3 Irrisept Nexplanon
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Joel Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/458608/joel-h-ross